Ladenburg Thalmann Financial Services’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$1K	Sell	185 -100	-35%	-$736	﹤0.01%	5288
2019 Q3	$2K	Hold	285	–	–	﹤0.01%	5054
2019 Q2	$2K	Buy	285 +100	+54%	+$857	﹤0.01%	5049
2019 Q1	$2K	Sell	185 -669	-78%	-$6.91K	﹤0.01%	5010
2018 Q4	$14K	Buy	854 +200	+31%	+$4.4K	﹤0.01%	4113
2018 Q3	$21K	Buy	654 +240	+58%	+$6.17K	﹤0.01%	3885
2018 Q2	$12K	Hold	414	–	–	﹤0.01%	4158
2018 Q1	$12K	Buy	414 +229	+124%	+$6.7K	﹤0.01%	4158
2017 Q4	$5K	Hold	185	–	–	﹤0.01%	4556
2017 Q3	$7K	Buy	185 +160	+640%	+$4.95K	﹤0.01%	4286
2017 Q2	$1K	Hold	25	–	–	﹤0.01%	4816
2017 Q1	$0	Hold	25	–	–	﹤0.01%	5039
2016 Q4	$0	Hold	25	–	–	﹤0.01%	5008
2016 Q3	$0	Buy	+25	New	+$235	﹤0.01%	4932
2014 Q2	–	Sell	-21	Closed	–	–	4029
2014 Q1	$0	Buy	+21	New	+$377	﹤0.01%	3903

Other funds holding AVEO

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

XSC

X-Square Capital Guaynabo, Puerto Rico $297M AUM 32.87% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Winton Group London, United Kingdom $2.85B AUM 30.73% 1-Year Est. Return

EWM

Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return

Ladenburg Thalmann Financial Services's AVEO Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services reduced its AVEO Pharmaceuticals, Inc. (AVEO) stake by 35% in Q4 2019, selling an estimated $736 and leaving 185 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #5288.

Ladenburg Thalmann Financial Services first reported a position in AVEO in Q1 2014 and has held it in 15 quarters since. The position peaked at $21K in Q3 2018. 61 funds tracked by Wall St. Rank hold AVEO as of Q4 2019.

Ladenburg Thalmann Financial Services held 185 shares of AVEO Pharmaceuticals, Inc. worth $1K as of Q4 2019.
Ladenburg Thalmann Financial Services sold 100 AVEO Pharmaceuticals, Inc. shares in Q4 2019, an estimated $736.
AVEO Pharmaceuticals, Inc. made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #5288 holding.
Ladenburg Thalmann Financial Services first reported a position in AVEO Pharmaceuticals, Inc. in Q1 2014 and has held it in 15 quarters since.
Ladenburg Thalmann Financial Services's AVEO Pharmaceuticals, Inc. position peaked at $21K in Q3 2018.
61 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.